Applied DNA Sciences, Inc. (ticker: APDN) is currently experiencing heightened trading activity, with a focus on potential price movements. Recent commentary suggests that traders are targeting a price squeeze above $2.20, with predictions of reaching $3.00 if this level is surpassed. There is a strategy being discussed among traders to accumulate shares while the price remains under $2, indicating a belief that shorts are currently active. The stock has been noted to have historically volatile movements, particularly in the biotech sector, driven by low floats and positive catalysts such as new contracts or clinical trial progress. However, no specific events have been confirmed to trigger a price run in the near term. As of the latest updates, APDN shares were trading around $1.84.